Janus Henderson Group PLC Bridge Bio Pharma, Inc. Transaction History
Janus Henderson Group PLC
- $194 Billion
- Q2 2025
A detailed history of Janus Henderson Group PLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Janus Henderson Group PLC holds 9,276,532 shares of BBIO stock, worth $588 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
9,276,532
Previous 7,171,399
29.35%
Holding current value
$588 Million
Previous $248 Million
61.57%
% of portfolio
0.21%
Previous 0.14%
Shares
25 transactions
Others Institutions Holding BBIO
# of Institutions
412Shares Held
187MCall Options Held
11.3MPut Options Held
1.93M-
Viking Global Investors LP18.6MShares$1.18 Billion2.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.5MShares$1.04 Billion0.01% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY13.3MShares$840 Million22.63% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$789 Million0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA7.9MShares$501 Million1.53% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $9.39B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...